Related Experiment Video
Updated: May 30, 2025
Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
Published on: February 7, 2018
Injection of Different Concentrations of Recombinant Humanized Type III Collagen Into the Dermis Promotes Type III
Haibo Xiang1, Yimou Sun, Yujie Chen
1All authors are affiliated with the Department of Plastic Surgery, Peking University Third Hospital, Haidian District, Beijing, China.
Background:
Type III recombinant humanized collagen (rhCol III) has a promising future in cosmetic applications.
Objective:
To investigate the histological changes associated with injection of different concentrations of Type III rhCol III into the dermis.
Materials And Methods:
Twenty mice were divided into a control, low-dose (LD) group, and high-dose (HD) group. The animals were euthanized 1, 2, 3, and 4 weeks after the injection.
Results:
Injections of rhCol III induced an increase in collagen formation in a concentration-dependent manner. Type I collagen (Col I) was upregulated in both HD and LD groups to varying extents, often similar to that of Col III. Fibroblast proliferation plays an important role in the deposition of Col I and Col III. Injections of rhCol III promoted angiogenesis at later stages, regardless of concentration dependency.
Conclusion:
Intradermal injections of rhCol III can promote fibroblast proliferation, enhancing the deposition of both Col I and Col III, and stimulating angiogenesis. Further studies are required to elucidate the mechanisms.
